Changes and determination of dosing recommendations for medicinal products recently authorised in the European Union

Bibliography

• European Public Assessment Reports (EPARs). Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/landing/epar_search.jsp&mid=WC0b01ac058001d124 [Last accessed 27 February 2015]
   Google Scholar
• ICH Topic E 4 Dose Response Information to Support Drug Registration. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500002834.pdf [Last accessed November 1994]
   Google Scholar
• Directive 2001/83/EC of the european parliament and of the council of 6 November 2001 on the Community code relating to medicinal products for human use. Available from: http://ec.europa.eu/health/files/eudralex/vol-1/dir_2001_83_consol_2012/dir_2001_83_consol_2012_en.pdf [Last accessed 6 November 2001]
   Google Scholar
• Trobalt (retigabine) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001245/human_med_001431.jsp&mid=WC0b01ac058001d124 [Last accessed 12 July 2013]
   Google Scholar
• Edurant (rilpivirine) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002264/human_med_001513.jsp&mid=WC0b01ac058001d124 [Last accessed 24 April 2014]
   Google Scholar
• Eviplera (emtricitabine/ rilpivirine/ tenofovir disoproxil) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002312/human_med_001514.jsp&mid=WC0b01ac058001d124 [Last accessed 20 December 2013]
   Google Scholar
• Votrient (pazopanib) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/001141/human_med_001337.jsp&mid=WC0b01ac058001d124 [Last accessed 05 July 2013]
   Google Scholar
• Esbriet (pirfenidone) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002154/human_med_001417.jsp&mid=WC0b01ac058001d124 [Last accessed 23 December 2014]
   Google Scholar
• Xalkori (crizotinib) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002489/human_med_001592.jsp&mid=WC0b01ac058001d124 [Last accessed 07 May 2014]
   Google Scholar
• Jakavi EU product label (SmPC). Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002464/WC500133223.pdf
   Google Scholar
• Jevtana (cabazitaxel) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002018/human_med_001428.jsp&mid=WC0b01ac058001d124 [Last accessed 04 May 2012]
   Google Scholar
• Halaven (eribulin) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002695/human_med_001656.jsp&mid=WC0b01ac058001d124 [Last accessed 03 November 2014]
   Google Scholar
• Iclusig (ponatinib) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002695/human_med_001656.jsp&mid=WC0b01ac058001d124 [Last accessed 03 November 2014]
   Google Scholar
• Nulojix (betalacept) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002098/human_med_001459.jsp&mid=WC0b01ac058001d124 [Last accessed 07 July 2011]
   Google Scholar
• Incivo (telaprevir) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002313/human_med_001487.jsp&mid=WC0b01ac058001d124 [Last accessed 26 June 2013]
   Google Scholar
• Zinforo (ceftaroline fosamil) product information. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002252/human_med_001584.jsp&mid=WC0b01ac058001d124 [Last accessed 18 September 2012]
   Google Scholar
• Cross J, Lee H, Westelinck A, et al. Postmarketing drug dosage changes of 499 FDA-approved new molecular entities, 1980–1999. Pharmacoepidemiol Drug Saf 2002;11:439-46
   PubMed Web of Science ®Google Scholar
• A guideline on Summary of Product Characteristics (SmPC). Available from: http://ec.europa.eu/health/files/eudralex/vol-2/c/smpc_guideline_rev2_en.pdf [Last accessed September 2009]
   Google Scholar
• International Conference on Harmonisation. Guidance for industry. dose–response information to support drug registration. Available from: http://www.ich.org/products/guidelines/efficacy/efficacy-single/article/dose-response-information-to-support-drug-registration.html [Last accessed 09 November 1994]
   Google Scholar
• Modelling and Simulation Working Group. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/contacts/PDCO/people_listing_000123.jsp&mid=WC0b01ac058063f485
   Google Scholar
• Concept paper on qualification and reporting of physiologically-based pharmacokinetic (PBPK) modelling and analyses. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/06/WC500169452.pdf [Last accessed 26 June 2014]
   Google Scholar
• Guideline on reporting the results of population pharmacokinetic analyses. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000370.jsp&mid=WC0b01ac0580032ec5
   Google Scholar
• Guideline on the Investigation of Drug Interactions. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2012/07/WC500129606.pdf [Last accessed 21 June 2012]
   Google Scholar
• Pharmacogenomics EMA guidance. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000411.jsp&mid=WC0b01ac058002958e
   Google Scholar
• Ehmann F, Caneva L, Prasad K, et al. Pharmacogenomic information in drug labels. european medicines agency perspective. Pharmacogenomics J 2015. [Epub ahead of print]
   PubMedGoogle Scholar
• Draft guideline on key aspects for the use of pharmacogenomic methodologies in the pharmacovigilance evaluation of medicinal products. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/01/WC500160232.pdf [Last accessed 10 January 2014]
   Google Scholar
• European Medicines Agency (EMA) workshop on the importance of dose finding and dose selection for the successful development, licensing and lifecycle management of medicinal products. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/events/2014/06/event_detail_000993.jsp&mid=WC0b01ac058004d5c3 [Last accessed 04-05 December 2014]
   Google Scholar
• EMA Scientific Advice and Protocol assistance. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000049.jsp&mid=WC0b01ac05800229b9
   Google Scholar
• EMA Paediatric-medicine development. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000414.jsp&mid=WC0b01ac0580025b8d
   Google Scholar
• EMA guidance on Marketing Authorisation Applications. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000197.jsp&mid=WC0b01ac058002251c
   Google Scholar
• Qualification of novel methodologies for medicine development. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000197.jsp&mid=WC0b01ac058002251c
   Google Scholar
• Guideline on the procedure for accelerated assessment pursuant to article 39 (8) of regulation (EC) No 726/2004. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/10/WC500005266.pdf [Last accessed 18 May 2006]
   Google Scholar
• Guideline on the scientific application and the practical arrangements necessary to implement commission regulation (ec) no 507/2006 on the conditional marketing authorisation for medicinal products for human use falling within the scope of regulation (EC) No 726/2004. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500004908.pdf [Last accessed 5 December 2006]
   Google Scholar
• Guideline on procedures for the granting of a marketing authorisation under exceptional circumstances, pursuant to article 14 (8) of regulation (EC) No 726/2004. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2009/10/WC500004883.pdf [Last accessed 15 December 2005]
   Google Scholar
• Notice to applicants volume 2A procedures for marketing authorisation Chapter 1 marketing authorisation. Available from: http://ec.europa.eu/health/files/eudralex/vol-2/a/vol2a_chap1_2013-06_en.pdf [Last accessed June 2013]
   Google Scholar